These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8555069)

  • 1. Decreased potency of MDR-modulators under serum conditions determined by a functional assay.
    Ludescher C; Eisterer W; Hilbe W; Hofmann J; Thaler J
    Br J Haematol; 1995 Nov; 91(3):652-7. PubMed ID: 8555069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effect of verapamil, cyclosporin A and SDZ PSC 833 on rhodamine 123 transport and cell cycle in vinblastine-resistant Chinese hamster ovary cells overexpressing P-glycoprotein.
    Pétriz J; Sánchez J; Bertrán J; García-López J
    Anticancer Drugs; 1997 Oct; 8(9):869-75. PubMed ID: 9402314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.
    Ludescher C; Thaler J; Drach D; Drach J; Spitaler M; Gattringer C; Huber H; Hofmann J
    Br J Haematol; 1992 Sep; 82(1):161-8. PubMed ID: 1358171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-Kit and functional drug efflux are correlated in de novo acute myeloid leukaemia.
    Sincock PM; Ashman LK
    Leukemia; 1997 Nov; 11(11):1850-7. PubMed ID: 9369417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of P-glycoprotein function using rhodamine 123.
    Pétriz J; García-López J
    Leukemia; 1997 Jul; 11(7):1124-30. PubMed ID: 9205001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.
    Twentyman PR; Rhodes T; Rayner S
    Eur J Cancer; 1994; 30A(9):1360-9. PubMed ID: 7999426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
    van der Kolk DM; de Vries EG; van Putten WJ; Verdonck LF; Ossenkoppele GJ; Verhoef GE; Vellenga E
    Clin Cancer Res; 2000 Aug; 6(8):3205-14. PubMed ID: 10955805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
    Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
    Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of multidrug resistance in de novo adult acute myeloid leukemia: variable efficacy of reverting agents in vitro. Eastern Cooperative Oncology Group.
    Paietta E; Andersen J; Racevskis J; Ashigbi M; Cassileth P; Wiernik PH
    Blood Rev; 1995 Mar; 9(1):47-52. PubMed ID: 7540903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
    Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H
    Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of SDZ-PSC833 on daunorubicin intracellular accumulation in bone marrow specimens from patients with acute myeloid leukaemia.
    Merlin JL; Guerci AP; Marchal S; Bour C; Colosetti P; Kataki A; Guerci O
    Br J Haematol; 1998 Nov; 103(2):480-7. PubMed ID: 9827923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhodamine 123 efflux modulation in the presence of low or high serum from CD56+ hematopoietic cells or CD34+ leukemic blasts by B9309-068, a newly designed pyridine derivative.
    Beck JF; Buchholz F; Ulrich WR; Boer R; Sanders KH; Niethammer D; Gekeler V
    Cancer Lett; 1998 Jul; 129(2):157-63. PubMed ID: 9719457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
    Quesada AR; García Grávalos MD; Fernández Puentes JL
    Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo.
    Watanabe T; Tsuge H; Oh-Hara T; Naito M; Tsuruo T
    Acta Oncol; 1995; 34(2):235-41. PubMed ID: 7718262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activity of P-glycoprotein in normal blood lymphocyte subsets.
    Ludescher C; Pall G; Irschick EU; Gastl G
    Br J Haematol; 1998 Jun; 101(4):722-7. PubMed ID: 9674746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.
    Lamy T; Drenou B; Grulois I; Fardel O; Jacquelinet C; Goasguen J; Dauriac C; Amiot L; Bernard M; Fauchet R
    Leukemia; 1995 Sep; 9(9):1549-55. PubMed ID: 7658724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833.
    Egashira M; Kawamata N; Sugimoto K; Kaneko T; Oshimi K
    Blood; 1999 Jan; 93(2):599-606. PubMed ID: 9885221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
    Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T
    Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of drug accumulation in P-glycoprotein-expressing and MRP-expressing human leukaemia cells.
    Davey MW; Hargrave RM; Davey RA
    Leuk Res; 1996 Aug; 20(8):657-64. PubMed ID: 8913319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.